Open Market Insiders Trades
This list includes insiders general transaction with codes filed in Form 4 from SEC:
- P - Open market or private purchase of non-derivative or derivative security
- S - Open market or private sale of non-derivative or derivative security
- V - Transaction voluntarily reported earlier than required
Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
---|---|---|---|---|---|---|
MGPI
|
Karen Seaberg
Director |
SELL
Open market or private sale
|
Indirect | 10,000 Reduced 1.5% |
$400,200
$40.02 p/Share
|
Oct 01
2020 |
CBZ
|
Benaree Pratt Wiley
Director |
SELL
Open market or private sale
|
Direct | 700 Reduced 7.25% |
$16,016
$22.88 p/Share
|
Oct 01
2020 |
SSTK
|
Jonathan Oringer
EXECUTIVE CHAIRMAN |
SELL
Open market or private sale
|
Direct | 27,945 Reduced 0.2% |
$1,479,967
$52.96 p/Share
|
Oct 01
2020 |
ATRC
|
Mark A Collar
Director |
SELL
Open market or private sale
|
Direct | 670 Reduced 0.82% |
$26,934
$40.2 p/Share
|
Oct 01
2020 |
GSHD
|
Robyn Mary Elizabeth Jones
Director |
SELL
Open market or private sale
|
Direct | 50,410 Reduced 8.63% |
$4,259,141
$84.49 p/Share
|
Oct 01
2020 |
PRAA
|
Martin Sjolund
President, PRA Group Europe |
SELL
Open market or private sale
|
Direct | 9,074 Reduced 21.61% |
$362,960
$40.0 p/Share
|
Oct 01
2020 |
SHAK
|
Daniel Harris Meyer
Director |
SELL
Open market or private sale
|
Indirect | 69,974 Reduced 3.06% |
$4,546,911
$64.98 p/Share
|
Oct 01
2020 |
ELF
|
Tarang Amin
Chief Executive Officer |
SELL
Open market or private sale
|
Indirect | 22,389 Reduced 0.46% |
$417,331
$18.64 p/Share
|
Oct 01
2020 |
RVMD
|
Barbara Weber |
SELL
Open market or private sale
|
Direct | 2,000 Reduced 52.52% |
$69,520
$34.76 p/Share
|
Oct 01
2020 |
BBIO
|
Michael Thomas Henderson
Chief Business Officer |
SELL
Open market or private sale
|
Direct | 10,000 Reduced 3.6% |
$387,900
$38.79 p/Share
|
Oct 01
2020 |
HURN
|
Debra Zumwalt
Director |
SELL
Open market or private sale
|
Direct | 205 Reduced 1.01% |
$8,073
$39.38 p/Share
|
Oct 01
2020 |
FSLY
|
Kelly Wright
Director |
SELL
Open market or private sale
|
Direct | 4,000 Reduced 50.99% |
$387,640
$96.91 p/Share
|
Oct 01
2020 |
PHR
|
David Linetsky
SVP, Life Sciences |
SELL
Open market or private sale
|
Direct | 4,477 Reduced 3.38% |
$140,488
$31.38 p/Share
|
Oct 01
2020 |
PHR
|
Evan Roberts
Chief Operating Officer |
SELL
Open market or private sale
|
Direct | 14,774 Reduced 2.11% |
$456,960
$30.93 p/Share
|
Oct 01
2020 |
CASH
|
Bradley C Hanson
Director |
SELL
Open market or private sale
|
Indirect | 9,133 Reduced 2.28% |
$180,651
$19.78 p/Share
|
Oct 01
2020 |
CASH
|
Glen William Herrick
EVP, Exec. Adv |
SELL
Open market or private sale
|
Direct | 8,854 Reduced 4.21% |
$175,132
$19.78 p/Share
|
Oct 01
2020 |
PLAB
|
Christopher J Progler
EVP, Chief Technology Officer |
SELL
Open market or private sale
|
Direct | 4,000 Reduced 3.31% |
$40,200
$10.05 p/Share
|
Oct 01
2020 |
ARQT
|
Howard G. Welgus
Director |
SELL
Open market or private sale
|
Direct | 2,200 Reduced 1.22% |
$58,696
$26.68 p/Share
|
Oct 01
2020 |
LPSN
|
William Wesemann
Director |
SELL
Open market or private sale
|
Indirect | 2,500 Reduced 90.9% |
$132,750
$53.1 p/Share
|
Oct 01
2020 |
DBI
|
Harvey L Sonnenberg
Director |
SELL
Open market or private sale
|
Direct | 23,000 Reduced 89.24% |
$128,800
$5.6 p/Share
|
Oct 01
2020 |
MORF
|
Alexey Lugovskoy
Chief Development Officer |
SELL
Open market or private sale
|
Direct | 1,627 Reduced 1.55% |
$44,905
$27.6 p/Share
|
Oct 01
2020 |
MORF
|
Robert E Farrell Jr
SVP Finance and CAO |
SELL
Open market or private sale
|
Direct | 3,279 Reduced 4.21% |
$90,533
$27.61 p/Share
|
Oct 01
2020 |
DCPH
|
Michael Douglas Taylor
Director |
SELL
Open market or private sale
|
Direct | 125,000 Reduced 100.0% |
$6,468,750
$51.75 p/Share
|
Oct 01
2020 |
IGMS
|
Bruce Keyt
CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Indirect | 1,000 Reduced 34.53% |
$73,590
$73.59 p/Share
|
Oct 01
2020 |
CSTL
|
Derek J Maetzold
Pres. & Chief Exec. Officer |
SELL
Open market or private sale
|
Direct | 12,640 Reduced 0.88% |
$654,499
$51.78 p/Share
|
Oct 01
2020 |
STOK
|
Huw M. Nash
Chief Business Officer |
SELL
Open market or private sale
|
Direct | 5,700 Reduced 100.0% |
$197,220
$34.6 p/Share
|
Oct 01
2020 |
EVER
|
Jayme Mendal
CEO and President |
SELL
Open market or private sale
|
Direct | 29,023 Reduced 12.13% |
$1,167,015
$40.21 p/Share
|
Oct 01
2020 |
EVER
|
Seth Birnbaum
President and CEO |
SELL
Open market or private sale
|
Direct | 5,078 Reduced 1.16% |
$206,065
$40.58 p/Share
|
Oct 01
2020 |
AXTI
|
Gary L Fischer
VICE PRESIDENT, CFO & CORP SEC |
SELL
Open market or private sale
|
Direct | 130 Reduced 0.06% |
$837
$6.44 p/Share
|
Oct 01
2020 |
PSNL
|
Richard Chen
CHIEF MEDICAL OFFICER AND EVP |
SELL
Open market or private sale
|
Direct | 40,000 Reduced 26.19% |
$878,800
$21.97 p/Share
|
Oct 01
2020 |
PCF
|
Phillip Goldstein
Director |
SELL
Open market or private sale
|
Direct | 8,301 Reduced 8.01% |
$69,147
$8.33 p/Share
|
Oct 01
2020 |
HARP
|
Holger Wesche
Chief Scientific Officer |
SELL
Open market or private sale
|
Direct | 10,000 Reduced 15.96% |
$166,100
$16.61 p/Share
|
Oct 01
2020 |
NTIP
|
Steven D. Heinemann
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 200 Reduced 0.01% |
$570
$2.85 p/Share
|
Oct 01
2020 |
FREQ
|
Christopher R. Loose
Chief Scientific Officer |
SELL
Open market or private sale
|
Direct | 8,000 Reduced 5.56% |
$150,720
$18.84 p/Share
|
Oct 01
2020 |
FREQ
|
David L. Lucchino |
SELL
Open market or private sale
|
Direct | 15,716 Reduced 4.24% |
$303,162
$19.29 p/Share
|
Oct 01
2020 |
AAOI
|
Chih Hsiang (Thompson) Lin
President and CEO |
SELL
Open market or private sale
|
Direct | 7,788 Reduced 0.97% |
$87,381
$11.22 p/Share
|
Oct 01
2020 |
APLT
|
Leslie D. Funtleyder |
SELL
Open market or private sale
|
Direct | 24,024 Reduced 50.95% |
$489,849
$20.39 p/Share
|
Oct 01
2020 |
NDRA
|
Renaud Bertrand Maloberti
Chief Commercial Officer |
SELL
Open market or private sale
|
Direct | 10,000 Reduced 11.55% |
$7,200
$0.72 p/Share
|
Oct 01
2020 |
MIK
|
Blackstone Management Associates V L.L.C.
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 10,000,000 Reduced 49.04% |
$100,200,005
$10.02 p/Share
|
Oct 01
2020 |
WORK
|
David Schellhase
General Counsel and Secretary |
SELL
Open market or private sale
|
Direct | 1,499 Reduced 0.51% |
$40,998
$27.35 p/Share
|
Oct 01
2020 |
WORK
|
Brandon Zell
Chief Accounting Officer |
SELL
Open market or private sale
|
Direct | 4,174 Reduced 2.32% |
$114,159
$27.35 p/Share
|
Oct 01
2020 |
WORK
|
Stewart Butterfield
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 110,745 Reduced 18.88% |
$3,064,314
$27.67 p/Share
|
Oct 01
2020 |
WORK
|
Robert Frati
Sr VP Sales, Customer Success |
SELL
Open market or private sale
|
Direct | 2,725 Reduced 0.86% |
$74,529
$27.35 p/Share
|
Oct 01
2020 |
WORK
|
Allen Shim
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 1,925 Reduced 0.82% |
$52,649
$27.35 p/Share
|
Oct 01
2020 |
WORK
|
Tamar Yehoshua
Chief Product Officer |
SELL
Open market or private sale
|
Direct | 49,083 Reduced 36.96% |
$1,342,420
$27.35 p/Share
|
Oct 01
2020 |
WORK
|
Cal Henderson
Chief Technology Officer |
SELL
Open market or private sale
|
Direct | 1,499 Reduced 3.44% |
$40,998
$27.35 p/Share
|
Oct 01
2020 |
ATAO
|
Erop Capital LLC |
SELL
Open market or private sale
|
Direct | 2,490 Reduced 0.0% |
$548
$0.22 p/Share
|
Oct 01
2020 |
SCPE
|
Glazer Capital, LLC
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 62 Reduced 0.0% |
$636
$10.26 p/Share
|
Oct 01
2020 |
BUDZ
|
Nicole M Breen
Secretary/Treasurer |
SELL
Open market or private sale
|
Indirect | 800 Reduced 0.0% |
$160
$0.2 p/Share
|
Oct 01
2020 |
APPS
|
Christopher Thomas Rogers
Director |
SELL
Open market or private sale
|
Direct | 30,000 Reduced 8.4% |
$1,030,500
$34.35 p/Share
|
Oct 01
2020 |